Expression of miRNAs 200c and 33a That Negatively Control HAS2 and HAS3 in Localized Prostate Cancer (2016)
- Authors:
- USP affiliated authors: SROUGI, MIGUEL - FM ; LEITE, KATIA RAMOS MOREIRA - FM
- Unidade: FM
- Subjects: NEOPLASIAS PROSTÁTICAS; EXPRESSÃO GÊNICA; PROSTÁTA (CIRURGIA); RESUMOS (EVENTOS)
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: Laboratory investigation
- ISSN: 0023-6837
- Volume/Número/Paginação/Ano: v. 96, suppl. 1, p. 250A-251A, res. 998, 2016
- Conference titles: Annual Meeting of the United States and Canadian Academy of Pathology
-
ABNT
MOURA, Caio M. et al. Expression of miRNAs 200c and 33a That Negatively Control HAS2 and HAS3 in Localized Prostate Cancer. Laboratory investigation. Baltimore: Faculdade de Medicina, Universidade de São Paulo. Disponível em: http://www.nature.com/labinvest/journal/v96/n1s/pdf/labinvest201610a.pdf. Acesso em: 28 mar. 2024. , 2016 -
APA
Moura, C. M., Reis, S. T., Pontes, J., Viana, N., Dip, N., Srougi, M., & Leite, K. R. M. (2016). Expression of miRNAs 200c and 33a That Negatively Control HAS2 and HAS3 in Localized Prostate Cancer. Laboratory investigation. Baltimore: Faculdade de Medicina, Universidade de São Paulo. Recuperado de http://www.nature.com/labinvest/journal/v96/n1s/pdf/labinvest201610a.pdf -
NLM
Moura CM, Reis ST, Pontes J, Viana N, Dip N, Srougi M, Leite KRM. Expression of miRNAs 200c and 33a That Negatively Control HAS2 and HAS3 in Localized Prostate Cancer [Internet]. Laboratory investigation. 2016 ; 96 250A-251A.[citado 2024 mar. 28 ] Available from: http://www.nature.com/labinvest/journal/v96/n1s/pdf/labinvest201610a.pdf -
Vancouver
Moura CM, Reis ST, Pontes J, Viana N, Dip N, Srougi M, Leite KRM. Expression of miRNAs 200c and 33a That Negatively Control HAS2 and HAS3 in Localized Prostate Cancer [Internet]. Laboratory investigation. 2016 ; 96 250A-251A.[citado 2024 mar. 28 ] Available from: http://www.nature.com/labinvest/journal/v96/n1s/pdf/labinvest201610a.pdf - PD-L1 expression in renal cell carcinoma clear cell type is related to unfavorable prognosis
- Treating metastatic prostate cancer with microRNA-145
- Comprehensive study of gene and microRNA expression related to epithelial-mesenchyamal transition in prostate cancer
- Genetic alterations related to Cystinuria – a genome wide assocaition analysis
- Controlling RECK miR21 promotes tumor cell invasion and is related to biochemical recurrence in prostate cancer
- GLUT1 expression is related to tumor recurrence and survival in renal cell carcinoma clear cell type
- Micro RNA 100, 145 and 373 in prostate cancer: From gene regulation to apoptosis
- Micro RNAs and Androgen Receptor in Prostate Cancer
- Shorter leukocyte telomere length is associated with severity of COVID-19 infection.
- Additional activation of the AR gene may be involved in the development of the castration resistance phenotype in prostate cancer
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas